BlueStar® Genomic Health Care Index

The BlueStar® Genomic Health Care Index (BDNA) tracks the performance of the largest and most liquid companies in the global genomic healthcare industry. This is a modified market cap-weighted index, and only includes companies that generate at least 50% of their revenue from health care therapies based on targeting or the modification of the genetic makeup of cells or uses mRNA, technology platforms that enable the development of genetics-based health care thearpies, or laboratory equipment or services used to test, code, or develop genetics-based health care companies.

Country and Sector Weightings

MVIS Sector Indices are pure-play sector indices. Companies must generate at least 50% of their revenues in the target sector to be eligible for index inclusion. Country and Sector weightings are based on the weightings of all index components in a certain country or sector.

CountryComponentsWeight
United States64 84.41%
Belgium1 0.99%
Germany3 2.78%
Netherlands1 1.32%
United Kingdom5 5.24%
Japan2 1.97%
New Zealand1 0.35%
China2 2.94%
Total79 100.00%
SectorComponentsWeight
Materials1 1.11%
Health Care78 98.89%
Total79 100.00%

Size Weightings

  • Large-Cap: companies with a market capitalisation above 6,000 mln USD
  • Mid-Cap: companies with a market capitalisation from 1,500 mln to 6,000 mln USD
  • Small-Cap: companies with a market capitalisation from 200 mln to 1,500 mln USD
  • Micro-Cap: companies with a market capitalisation up to 200 mln USD
SizeMarket CapComponentsWeight
Large-Cap354,551,176,600 USD11 12.88%
Mid-Cap95,989,808,800 USD30 40.69%
Small-Cap28,626,985,840 USD36 44.96%
Micro-Cap380,697,720 USD2 1.46%
Total479,548,668,960 USD79 100.00%
Up